2-(Diethoxymethyl)oxirane, 90%,Containing phenylacetonitrile stabilizer, 100mg

5-Bromo-6-methyl-3-nitropyridin-2-amine, 95.0%, 1g

2-chloro-1-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethan-1-one, 95.0%, 1g

6,8-Dibromoimidazo[1,2-a]pyrazine>98.0%(GC)5g

2,4-Dichloro-6-(propan-2-yl)pyrimidine, 98+%, 100mg

2-Acetyl-4-chlorothiophene, 95.0%, 10g

3,5-dimethyl-1H-pyrazol-4-ol, 95.0%, 1g

Odanacatib, 99.82%, 1mg

Obiettivo piano PLPHi 20x/0.40 contrasto di fase IOS corretto all'infinito

(4-Chloro-2-fluorophenyl)(6-chloro-2-methyl-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-3-yl)methanone, 98%, 100mg

N-(2-Aminoethyl)aminomethyl Polystyrene Resin cross-linked with 1% DVB (50-100mesh) (3.1-3.5mmol/g)25g

Ethyl N-[(2-Boc-amino)ethyl]glycinatehydrochloride, 97.0%, 5g

7-Bromo-[1,3]oxazolo[4,5-b]pyridine, 95+%, 100mg